These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 5824923)
21. [Metabolism of phenylbutazone in the liver (author's transl)]. González Macías J; De Castro del Pozo S Med Klin; 1976 Sep; 71(36):1434-8. PubMed ID: 958107 [TBL] [Abstract][Full Text] [Related]
23. [Current status of hepatic and biliary drug therapy. Part I]. Donatelli L; Marmo E Clin Ter; 1976 Mar; 76(5):395-409. PubMed ID: 791566 [No Abstract] [Full Text] [Related]
25. [Effect of phenobarbital on the intrahepatic metabolism of bilirubin]. Oleĭnik AN Klin Med (Mosk); 1978 Feb; 56(2):27-33. PubMed ID: 416290 [No Abstract] [Full Text] [Related]
26. Alterations produced in the endoplasmic reticulum by carbon tetrachloride. Smuckler EA Panminerva Med; 1976; 18(9-10):292-309. PubMed ID: 980529 [No Abstract] [Full Text] [Related]
27. [Chronic intrahepatic cholestasis following chlorpromazine; treated using phenobarbital]. Nerad V; Skaunic V Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1976; 19(5):721-7. PubMed ID: 1088626 [No Abstract] [Full Text] [Related]
28. [Liver damage due to drugs. I]. Fossati C Clin Ter; 1974 Jan; 68(1):75-85. PubMed ID: 4595636 [No Abstract] [Full Text] [Related]
29. [Pathophysiology and clinical aspects of intrahepatic cholestasis]. Kühn HA; Richter E Med Klin; 1970 Jan; 65(1):1-8. PubMed ID: 4929317 [No Abstract] [Full Text] [Related]
31. [Metabolic capacity of the liver for drugs in hepatobiliary patients]. González Macias J; Herreros Fernández V; De Castro Del Pozo S Rev Clin Esp; 1975 Jan; 136(2):123-30. PubMed ID: 1121588 [No Abstract] [Full Text] [Related]
32. [Toxic liver injury]. Bode C; Martini GA Med Klin; 1970 Jan; 65(1):8-16. PubMed ID: 4926626 [No Abstract] [Full Text] [Related]
33. Experimental alterations of the ergastoplasm of the mouse liver. Wilson JW; Leduc EH Rev Int Hepatol; 1967; 17(8):883-93. PubMed ID: 5600369 [No Abstract] [Full Text] [Related]
34. [Phenobarbital treatment of benign recurrent intrahepatic cholestasis]. Braun W; Wöckel W; Giertler U; Vollmar F Schweiz Med Wochenschr; 1972 Dec; 102(48):1769-72. PubMed ID: 4645801 [No Abstract] [Full Text] [Related]
35. Potentiation of carbon-tetrachloride hepato-nephrotoxicity by phenobarbital in man, a case report. Mahieu P; Geubel A; Rahier J; Scailteur V; Dieryck JP; Lauwerys R Int J Clin Pharmacol Res; 1983; 3(6):427-30. PubMed ID: 6678833 [TBL] [Abstract][Full Text] [Related]
36. [Causes and types of cholestasis from a biopsy viewpoint]. Roschlau G Dtsch Z Verdau Stoffwechselkr; 1983; 43(2):49-55. PubMed ID: 6872919 [TBL] [Abstract][Full Text] [Related]
37. [Rules for the histological evaluation of drug-induced liver lesions]. Bianchi L; De Groote J; Desmet V; Gedigk P; Korb G; Popper H; Poulsen H; Scheuer PJ; Schmid M; Thaler H; Wepler W Dtsch Med Wochenschr; 1975 Aug; 100(35):1746-50. PubMed ID: 1157673 [No Abstract] [Full Text] [Related]
38. [Mechanism of the hypobilirubinemic effect of prednisolone and some pyrazolone derivatives]. Pidémskiĭ EL; Mardanova LG Farmakol Toksikol; 1976; 39(1):114-9. PubMed ID: 943312 [TBL] [Abstract][Full Text] [Related]
39. Bile formation in rats with acute liver damage from carbon tetrachloride. Juggi JS Indian J Physiol Pharmacol; 1977; 21(4):311-22. PubMed ID: 614279 [TBL] [Abstract][Full Text] [Related]